More to B: the growing evidence to inform targeting B cells in scleroderma
Rheumatology (Oxford)
.
2023 May 2;62(5):1730-1732.
doi: 10.1093/rheumatology/keac677.
Authors
Silvia Laura Bosello
1
,
Edward M Vital
2
3
,
Francesco Del Galdo
2
3
Affiliations
1
UOC di Reumatologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
2
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
3
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
PMID:
36469308
PMCID:
PMC10152272
DOI:
10.1093/rheumatology/keac677
No abstract available
Publication types
Editorial
Comment
MeSH terms
B-Lymphocytes
Humans
Scleroderma, Localized*
Scleroderma, Systemic*